U.S. stocks kicked off Monday in mixed moods, despite an initial rally following the announcement of a new trade agreement between the U.S. and the EU. At the time of publication, the US500 is up 0.10%, the US100 has gained 0.40%, while the small-cap index US2000 is down 0.05%. The strengthening U.S. dollar is weighing on equity markets.
The main story of the day is, of course, the trade deal with the European Union announced by Trump on Sunday. However, investor optimism quickly faded after a closer look at the announced agreement. EU Commission President von der Leyen made vague promises regarding potential investments and purchases from the United States. This is also only a preliminary agreement with no legal foundation to ensure those promises become reality. Moreover, the deal excludes key sectors such as pharmaceuticals and steel.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appMost sectors within the US500 index are in the red today, except for energy and new technologies. The U.S. dollar continues to rally strongly; the USDIDX is up 0.70% to 98,000 points. Investor attention will now turn to key upcoming quarterly earnings releases and the Fed meeting on Wednesday.
US500
The US500 index opened with a gap to the upside. However, since then, futures have pared some of the initial gains. The index is currently up 0.10% at 6,430 points.
Company News
Tesla (TSLA.US) rose 3.50% after confirming a $16.5B semiconductor deal with Samsung, running through 2033. The Texas fab will produce Tesla’s next-gen AI6 chips, with Elon Musk personally overseeing progress.
Alibaba (BABA.US) gained 1.92% after unveiling its AI-powered smart glasses, “Quark AI Glasses,” set to launch in China in late 2025. Powered by Alibaba’s own language model, the device targets the growing AI wearables market.
Atai Life Sciences (ATAI.US) dropped 12% after partner Recognify Life Sciences’ Phase 2b trial for inidascamine failed to meet its primary endpoint for schizophrenia-related cognitive impairment, prompting a refocus on Atai’s psychedelic pipeline.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
